Insights

Explore our thoughts and insights on learning science and the education space.

Beyond Clinical Data: Preparing Market Access Teams to Communicate RWE and HEOR

September 10, 2026; By ERS Team

Real-world evidence (RWE) and health economics and outcomes research (HEOR) have become standard inputs into payer decisions, yet most Market Access field training still centers on the clinical dossier.

MSL Training That Moves KOLs: Why Your Team Knows the Data and Why That’s Not Enough

July 28, 2026; By ERS Team

Traditional training metrics may show that MSLs know the science, but they do not reveal whether they can turn that knowledge into meaningful scientific exchanges, influence KOLs, and generate actionable insights.

You’ve Got 90 Seconds with That HCP. Is Your Pharma Field Team Ready?

June 11, 2026; By ERS Team

In today’s commercial pharmaceutical environment, physician access is no longer guaranteed and time is the most constrained commodity of all.

Pharma Field Force Differentiation: Why Sales Training Must Shift from Completion to Outcomes

June 10, 2026; By ERS Team

Differentiation is one of the most persistent challenges facing today’s pharmaceutical field teams.